Cafepharma Today

June 11 2025 - BMS expands radiopharma pipeline via RayzeBio's $1.3B prostate cancer drug deal
BMS expands radiopharma pipeline via RayzeBio's $1.3B prostate cancer drug deal
Novo Nordisk, Deep Apple launch drug discovery alliance for weight loss oral therapies
Eli Lilly works out $650M Juvena pact to find muscle-boosting drugs
Nvidia announces massive new initiatives in pharma and clinical research
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

[video]Sanofi + Genzyme: Possible Deal?
Yahoo/CNBC
Wednesday, January 12, 2011 - 9:48am
tags:
Genzyme, Sanofi
Genzyme expects profit, revenue boost in 4th qtr
Yahoo/AP
Wednesday, January 12, 2011 - 9:47am
tags:
Genzyme, earnings
Amarin CEO Seeks Adviser After Buyer, Partner Interest
Bloomberg
Wednesday, January 12, 2011 - 9:46am
tags:
Amarin, M&A
Merck Vaccine Cuts Risk of Shingles by Half, Researchers Find
Bloomberg
Wednesday, January 12, 2011 - 9:45am
tags:
Merck, shingles, vaccines, Zostavax
Roche, Avastin And An Influential Cancer Doc Panel
Pharmalot
Tuesday, January 11, 2011 - 2:41pm
tags:
Avastin, Roche, Genentech, FDA, breast cancer
Statins May Be Harmful After Stroke
Yahoo/Health Day
Tuesday, January 11, 2011 - 2:39pm
tags:
statins, stroke
PDLI's Synagis Lawsuit Invalidated
Yahoo/Zacks.com
Tuesday, January 11, 2011 - 2:36pm
tags:
Synagis, PDL Biopharma, MedImmune, lawsuits, Abbott Laboratories
Here's How Genzyme May Be Failing You
Motley Fool
Tuesday, January 11, 2011 - 2:35pm
tags:
Genzyme, Novartis, AstraZeneca, GSK
Eli Lilly, Boehringer Ingelheim launch collaboration to develop diabetes treatments
Yahoo/AP
Tuesday, January 11, 2011 - 12:45pm
tags:
Eli Lilly, Boehringer Ingelheim, diabetes
Is Forest Labs' Stock Cheap by the Numbers?
Motley Fool
Tuesday, January 11, 2011 - 12:43pm
tags:
Forest Labs
Merck Says Emerging Market Drugs to Generate 25% of 2013 Revenue
Bloomberg
Tuesday, January 11, 2011 - 12:43pm
tags:
Merck, emerging markets
Merck Reports FDA Acceptance of NDA for Janumet
Bloomberg
Tuesday, January 11, 2011 - 12:41pm
tags:
Merck, FDA, Janumet, NDA, diabetes
CVRs could become a new trend in biotech M&A
Marketwatch
Tuesday, January 11, 2011 - 12:33pm
tags:
CVRs, biotech, M&A, Genzyme, Sanofi
Qiagen Buys Stake in German Start-Up, Gaining Biomarker Access
Bloomberg
Tuesday, January 11, 2011 - 12:32pm
tags:
Qiagen, biomarkers, Germany, Alacris Theranostics GmbH
Celgene's Drop Could Provide a Great Opportunity
Seeking Alpha
Tuesday, January 11, 2011 - 12:31pm
tags:
Celgene, earnings
Charge This! A Fired Merck Sales Rep & A Credit Card
Pharmalot
Tuesday, January 11, 2011 - 12:29pm
tags:
Merck, drug reps
Galapagos updates progress in GSK arthritis trials
Marketwatch
Tuesday, January 11, 2011 - 12:28pm
tags:
GSK, Galapagos, arthritis
Human Genome sets Lupus drug sales goal
Marketwatch
Tuesday, January 11, 2011 - 12:27pm
tags:
lupus, Human Genome Sciences, Benlysta
Endo Pharma shares drop as FDA rejects application
Yahoo/AP
Monday, January 10, 2011 - 8:13pm
tags:
FDA, Endo, Opana ER
Opko Teams Up With Bristol-Myers For Alzheimers Effort
Forbes
Monday, January 10, 2011 - 8:12pm
tags:
OPKO Health, Alzheimer's disease, Bristol-Myers Squibb

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Novo Nordisk's Canadian Mistake
In the Pipeline
The Bethesda Declaration
In the Pipeline
Taurine and Aging: Is There Anything to It?
In the Pipeline
Cleaning Up the Medical Literature
In the Pipeline
Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.